Dmitry Balyasny’s Evolent Health EVH Stock Holding History

Dmitry Balyasny’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-100,000	Closed	-$3.07M	–	2948
2022 Q2	$3.07M	Buy	+100,000	New	+$2.91M	0.01%	1167
2022 Q1	–	Sell	-113,900	Closed	-$3.15M	–	2575
2021 Q4	$3.15M	Buy	113,900 +13,900	+14%	+$399K	0.01%	1017
2021 Q3	$3.1M	Buy	+100,000	New	+$2.4M	0.01%	980
2020 Q4	–	Sell	-50,000	Closed	-$621K	–	1433
2020 Q3	$621K	Buy	+50,000	New	+$588K	﹤0.01%	1072

Other funds holding EVH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Dmitry Balyasny's EVH Position: Q2 2026 in Review

Dmitry Balyasny reduced its Evolent Health (EVH) stake by 92% in Q2 2026, selling an estimated $1.35M and leaving 30,523 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #2845.

Dmitry Balyasny first reported a position in EVH in Q4 2017 and has held it in 20 quarters since. The position peaked at $13.6M in Q3 2023. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

Dmitry Balyasny held 30,523 shares of Evolent Health worth $165K as of Q2 2026.
Dmitry Balyasny sold 351,226 Evolent Health shares in Q2 2026, an estimated $1.35M.
Evolent Health made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2845 holding.
Dmitry Balyasny first reported a position in Evolent Health in Q4 2017 and has held it in 20 quarters since.
Dmitry Balyasny's Evolent Health position peaked at $13.6M in Q3 2023.
198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.